DARZALEX FASPRO®
(daratumumab and hyaluronidase-fihj)
Medical inquiries
This information is intended for US healthcare professionals to access current scientific information about J&J Innovative Medicine products. It is prepared by Medical Information and is not intended for promotional purposes, nor to provide medical advice.
DARZALEX FASPRO® (daratumumab and hyaluronidase-fihj)
Medical Information
DARZALEX FASPRO - Latex Content
Last Updated: 09/17/2024
SUMMARY
- DARZALEX FASPRO is supplied as a colorless to yellow and clear to opalescent preservative-free solution for subcutaneous injection and is supplied in single-dose vials.1
The immediate container does not contain latex/natural rubber. However, it cannot be guaranteed that the immediate container has not come in contact with latex during the manufacturing or packaging process (e.g., latex gloves).2 - The materials do not contain latex as an ingredient. However, it cannot be guaranteed that the materials have not come in contact with latex during the manufacturing or packaging process (e.g. latex gloves). There is no information on latex (natural rubber) for rHuPH20 (hyaluronidase).2
Literature Search
A literature search of MEDLINE®